BioPharm International-12-16-2013

Clinical-stage biopharmaceutical company Ambrx leverages its site-specific bioconjugation technology through partnerships.

The little-known exception to the patent term extension law is potentially valuable but easy to miss.

Partnering with CDMOs can help bridge the innovation gap.

NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

The biopharmaceutical industry must consider new ways to manage innovation, including how product data are handled.

Caution should be taken when planning to crowdfund a biopharmaceutical startup.

Merck Serono fuels innovation with an integrated research, development, and manufacturing program and seed funding for startups.